相关实验视频
Updated: May 27, 2026
07:02
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
7.5K
研究信:免疫检查点抑制剂对抗甲状腺癌
1Department of Nuclear Medicine, Shanghai Jiao Tong University Affiliated Sixth People's Hospital South Campus, Shanghai, China.
International journal of surgery (London, England)
|July 3, 2025
概括
免疫检查点抑制剂 (ICI) 在甲状腺癌治疗中表现有前途,许多临床试验重点关注特定的亚型和组合治疗. 需要进一步的研究来改善甲状腺癌ICI试验的积极结果.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 临床试验 临床试验
背景情况:
- 甲状腺癌治疗领域正在不断发展.
- 免疫检查点抑制剂 (ICI) 是一个有前途的治疗途径.
- 了解临床试验环境对于推进ICI治疗至关重要.
研究的目的:
- 在甲状腺癌中全面分析免疫检查点抑制剂 (ICI) 的全球临床试验.
- 描绘目前的景观和未来的前景在甲状腺癌ICI治疗.
主要方法:
- 使用Trialtrove数据库对临床试验进行系统分析.
- 关键词:"免疫检查点抑制剂"",甲状腺瘤学".
- 确定了113个相关的临床试验.
主要成果:
- 临床试验活动在2020年达到顶峰,主要是II期和III期研究.
- 布利祖马布是研究最多的单一疗法;组合 (例如,布利祖马布-伦瓦提尼布) 也被调查.
- BRAF和免疫检查点标志物是关键生物标志物;只有五项试验报告了积极的结果,突出了对新组合和亚型特定方法的需求.
结论:
- 有价值的洞察力到目前的状况甲状腺癌临床试验涉及ICIs.
- 强调了特定甲状腺癌亚型和新型组合疗法的重要性.
- 为未来基于ICI治疗甲状腺癌的研究和开发提供了基础.
相关概念视频
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:29Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...